Overview:
Geneyx offers a superior NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders. Our AI-based analysis platform streamlines the diagnostics process, from the raw genetic data to the final clinical report. Geneyx develops unique technologies and utilizes diverse databases in the interpretation of WGS (Whole Genome Sequencing), WES, and gene panels. We aim to enrich disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.
Increases diagnostic yield and empowers clinicians with rapid clinical decision support
Utilizes the world’s largest unified global knowledge base for interrogating genetic-based diseases and disorders
Reduces the time associated with analysis, interpretation, and reporting by 95% through a streamlined, automated, and simplified workflow
Reducing overhead costs through automation and machine learning requiring less hands-on time
Reducing liability to clinical providers through auditable, evidence-based reports
Partner Program Description:
We are looking for qualified and experienced SaaS distributors, to engage hospitals and genetic labs in a certain region and generate sales.